Aetiology, genetics and prevention of secondary neoplasms in adult cancer survivors (Q38093037)

28 August 2017

title

Aetiology, genetics and prevention of secondary neoplasms in adult cancer survivors (English)

1 reference

28 August 2017

1 reference

1

Lois B Travis

1 reference

28 August 2017

author name string

Wendy Demark Wahnefried

2

1 reference

28 August 2017

James M Allan

3

1 reference

28 August 2017

Marie E Wood

4

1 reference

28 August 2017

Andrea K Ng

5

1 reference

28 August 2017

language of work or name

English

0 references

publication date

26 March 2013

1 reference

Nature Reviews Clinical Oncology

28 August 2017

published in

1 reference

28 August 2017

volume

10

1 reference

28 August 2017

issue

5

1 reference

28 August 2017

page(s)

289-301

1 reference

Cancer treatment and survivorship statistics, 2012

28 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038/NRCLINONC.2013.41

Long-term survival and competing causes of death in patients with early-stage Hodgkin's disease treated at age 50 or younger

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRCLINONC.2013.41

Cancer survivorship--genetic susceptibility and second primary cancers: research strategies and recommendations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRCLINONC.2013.41

Second cancers after testicular cancer diagnosed after 1980 in Sweden

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRCLINONC.2013.41

Treatment-specific risks of second malignancies and cardiovascular disease in 5-year survivors of testicular cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRCLINONC.2013.41

Increased risk of colon cancer after external radiation therapy for prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRCLINONC.2013.41

Radiation-induced sarcomas after radiotherapy for breast carcinoma: a large-scale single-institution review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRCLINONC.2013.41

Radiation dose and risk of soft tissue and bone sarcoma after breast cancer treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRCLINONC.2013.41

Effect of breast cancer radiotherapy and cigarette smoking on risk of second primary lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRCLINONC.2013.41

Roles of radiotherapy and chemotherapy in the development of contralateral breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRCLINONC.2013.41

Dose to the contralateral breast from radiotherapy and risk of second primary breast cancer in the WECARE study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRCLINONC.2013.41

Proportion of second cancers attributable to radiotherapy treatment in adults: a cohort study in the US SEER cancer registries

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRCLINONC.2013.41

Reduced Treatment Intensity in Patients with Early-Stage Hodgkin's Lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRCLINONC.2013.41

Radiotherapy for stages IIA/B testicular seminoma: final report of a prospective multicenter clinical trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRCLINONC.2013.41

Cancer incidence after retinoblastoma. Radiation dose and sarcoma risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRCLINONC.2013.41

Second malignancies after Ewing's sarcoma: radiation dose-dependency of secondary sarcomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRCLINONC.2013.41

Lung cancer following chemotherapy and radiotherapy for Hodgkin's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRCLINONC.2013.41

Roles of radiation dose and chemotherapy in the etiology of stomach cancer as a second malignancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRCLINONC.2013.41

New primary neoplasms of the central nervous system in survivors of childhood cancer: a report from the Childhood Cancer Survivor Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRCLINONC.2013.41

Risk of second primary thyroid cancer after radiotherapy for a childhood cancer in a large cohort study: an update from the childhood cancer survivor study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRCLINONC.2013.41

Primary thyroid cancer after a first tumour in childhood (the Childhood Cancer Survivor Study): a nested case-control study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRCLINONC.2013.41

Breast cancer risk in female survivors of Hodgkin's lymphoma: lower risk after smaller radiation volumes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRCLINONC.2013.41

Dose to normal tissues outside the radiation therapy patient's treated volume: a review of different radiation therapy techniques

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRCLINONC.2013.41

Radiobiological risk estimates of adverse events and secondary cancer for proton and photon radiation therapy of pediatric medulloblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRCLINONC.2013.41

A comparative study on the risk of second primary cancers in out-of-field organs associated with radiotherapy of localized prostate carcinoma using Monte Carlo-based accelerator and patient models

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRCLINONC.2013.41

Effect of intensity-modulated pelvic radiotherapy on second cancer risk in the postoperative treatment of endometrial and cervical cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRCLINONC.2013.41

Risk of developing second cancer from neutron dose in proton therapy as function of field characteristics, organ, and patient age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRCLINONC.2013.41

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRCLINONC.2013.41

Lenalidomide after stem-cell transplantation for multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRCLINONC.2013.41

Increased risk of myelodysplasia and leukaemia after etoposide, cisplatin, and bleomycin for germ-cell tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRCLINONC.2013.41

Advances in the understanding of susceptibility to treatment-related acute myeloid leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRCLINONC.2013.41

Therapy-related myeloid leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRCLINONC.2013.41

Increased incidence of transformation and myelodysplasia/acute leukemia in patients with Waldenström macroglobulinemia treated with nucleoside analogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRCLINONC.2013.41

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRCLINONC.2013.41

Poor survival of treatment-related acute nonlymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRCLINONC.2013.41

Pooled analysis of clinical and cytogenetic features in treatment-related and de novo adult acute myeloid leukemia and myelodysplastic syndromes based on a consecutive series of 761 patients analyzed 1976-1993 and on 5098 unselected cases reported i

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRCLINONC.2013.41

Karyotype is an independent prognostic parameter in therapy-related acute myeloid leukemia (t-AML): an analysis of 93 patients with t-AML in comparison to 1091 patients with de novo AML

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRCLINONC.2013.41

Long-Term Outcomes of Myeloid Growth Factor Treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRCLINONC.2013.41

Acute myeloid leukemia or myelodysplastic syndrome following use of granulocyte colony-stimulating factors during breast cancer adjuvant chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRCLINONC.2013.41

Acute myeloid leukemia or myelodysplastic syndrome in randomized controlled clinical trials of cancer chemotherapy with granulocyte colony-stimulating factor: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRCLINONC.2013.41

Risk factors associated with secondary sarcomas in childhood cancer survivors: a report from the childhood cancer survivor study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRCLINONC.2013.41

Lung cancer after Hodgkin's disease: a nested case-control study of the relation to treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRCLINONC.2013.41

Roles of radiotherapy and smoking in lung cancer following Hodgkin's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRCLINONC.2013.41

Second cancer risk after chemotherapy for Hodgkin's lymphoma: a collaborative British cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRCLINONC.2013.41

Second cancers and late toxicities after treatment of aggressive non-Hodgkin lymphoma with the ACVBP regimen: a GELA cohort study on 2837 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRCLINONC.2013.41

Secondary gastrointestinal cancer in childhood cancer survivors: a cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRCLINONC.2013.41

Bladder and kidney cancer following cyclophosphamide therapy for non-Hodgkin's lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRCLINONC.2013.41

Bladder cancer in cancer patients: population-based estimates from a large Swedish study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRCLINONC.2013.41

Chemotherapy and thyroid cancer risk: a report from the childhood cancer survivor study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRCLINONC.2013.41

Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRCLINONC.2013.41

Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRCLINONC.2013.41

Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 10-year analysis of the ATAC trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRCLINONC.2013.41

American Society of Clinical Oncology clinical practice guideline: update on adjuvant endocrine therapy for women with hormone receptor-positive breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRCLINONC.2013.41

Increasing incidence of late second malignancies after conditioning with cyclophosphamide and total-body irradiation and autologous bone marrow transplantation for non-Hodgkin's lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRCLINONC.2013.41

Solid cancers after allogeneic hematopoietic cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRCLINONC.2013.41

Solid cancers after bone marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRCLINONC.2013.41

Subsequent Malignant Neoplasms after Hematopoietic Cell Transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRCLINONC.2013.41

Risk factors for lymphoproliferative disorders after allogeneic hematopoietic cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRCLINONC.2013.41

Post transplant lymphoproliferative disorders: risk, classification, and therapeutic recommendations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRCLINONC.2013.41

Increased risk of breast cancer among survivors of allogeneic hematopoietic cell transplantation: a report from the FHCRC and the EBMT-Late Effect Working Party

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRCLINONC.2013.41

Solid cancers after bone marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRCLINONC.2013.41

Second solid cancers after allogeneic hematopoietic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRCLINONC.2013.41

Secondary solid cancers after allogeneic hematopoietic cell transplantation using busulfan-cyclophosphamide conditioning

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRCLINONC.2013.41

Nonmelanoma skin and mucosal cancers after hematopoietic cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRCLINONC.2013.41

Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRCLINONC.2013.41

Calculation of risk of colorectal and endometrial cancer among patients with Lynch syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRCLINONC.2013.41

Cancer risks associated with germline mutations in MLH1, MSH2, and MSH6 genes in Lynch syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRCLINONC.2013.41

The risk of ovarian cancer after breast cancer in BRCA1 and BRCA2 carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRCLINONC.2013.41

The risk of contralateral breast cancer in patients from BRCA1/2 negative high risk families as compared to patients from BRCA1 or BRCA2 positive families: a retrospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRCLINONC.2013.41

Risk of asynchronous contralateral breast cancer in noncarriers of BRCA1 and BRCA2 mutations with a family history of breast cancer: a report from the Women's Environmental Cancer and Radiation Epidemiology Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRCLINONC.2013.41

Risks of primary extracolonic cancers following colorectal cancer in lynch syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRCLINONC.2013.41

Metachronous colorectal cancer risk for mismatch repair gene mutation carriers: the advantage of more extensive colon surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRCLINONC.2013.41

DNA damage responses: mechanisms and roles in human disease: 2007 G.H.A. Clowes Memorial Award Lecture

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRCLINONC.2013.41

Two metachronous tumors in the radiotherapy fields of a patient with Li-Fraumeni syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRCLINONC.2013.41

Relative frequency and morphology of cancers in carriers of germline TP53 mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRCLINONC.2013.41

Identification of a novel TP53 cancer susceptibility mutation through whole-genome sequencing of a patient with therapy-related AML.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRCLINONC.2013.41

Risk of new cancers after radiotherapy in long-term survivors of retinoblastoma: an extended follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRCLINONC.2013.41

Second primary neoplasms in patients with retinoblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRCLINONC.2013.41

Second primary tumors in neurofibromatosis 1 patients treated for optic glioma: substantial risks after radiotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRCLINONC.2013.41

The incidence of Gorlin syndrome in 173 consecutive cases of medulloblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRCLINONC.2013.41

Second cancers after medulloblastoma: population-based results from the United States and Sweden

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRCLINONC.2013.41

Secondary malignant neoplasms after Wilms tumor: an international collaborative study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRCLINONC.2013.41

Radiation exposure, the ATM Gene, and contralateral breast cancer in the women's environmental cancer and radiation epidemiology study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRCLINONC.2013.41

Radiation-sensitive genetically susceptible pediatric sub-populations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRCLINONC.2013.41

Breast cancer susceptibility-A new look at an old model

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRCLINONC.2013.41

The prevalence of CDKN2A germ-line mutations and relative risk for cutaneous malignant melanoma: an international population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRCLINONC.2013.41

Interaction of CDKN2A and sun exposure in the etiology of melanoma in the general population

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRCLINONC.2013.41

Geographical variation in the penetrance of CDKN2A mutations for melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRCLINONC.2013.41

A genome-wide association study identifies six susceptibility loci for chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRCLINONC.2013.41

IRF4 polymorphism rs872071 and risk of Hodgkin lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRCLINONC.2013.41

IRF4 variants have age-specific effects on nevus count and predispose to melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRCLINONC.2013.41

GWAS identifies novel susceptibility loci on 6p21.32 and 21q21.3 for hepatocellular carcinoma in chronic hepatitis B virus carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRCLINONC.2013.41

Global burden of cancers attributable to infections in 2008: a review and synthetic analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRCLINONC.2013.41

Second malignant neoplasms: assessment and strategies for risk reduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRCLINONC.2013.41

Role of Genetic Susceptibility in Development of Treatment-Related Adverse Outcomes in Cancer Survivors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRCLINONC.2013.41

Genetic variation in XPD predicts treatment outcome and risk of acute myeloid leukemia following chemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRCLINONC.2013.41

Variants at 6q21 implicate PRDM1 in the etiology of therapy-induced second malignancies after Hodgkin's lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRCLINONC.2013.41

Influence of continued smoking on the incidence of secondary primary cancers involving mouth, pharynx, and larynx

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRCLINONC.2013.41

Influence of smoking cessation after diagnosis of early stage lung cancer on prognosis: systematic review of observational studies with meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRCLINONC.2013.41

Second primary malignancy of the aerodigestive tract in patients treated for cancer of the oral cavity and larynx

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRCLINONC.2013.41

Second primary tumors in patients with upper aerodigestive tract cancers: joint effects of smoking and alcohol (United States).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRCLINONC.2013.41

Tobacco smoking and increased risk of death and progression for patients with p16-positive and p16-negative oropharyngeal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRCLINONC.2013.41

Influence of the persistence of tobacco and alcohol use in the appearance of second neoplasm in patients with a head and neck cancer. A case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRCLINONC.2013.41

Alcohol intake and cigarette smoking and risk of a contralateral breast cancer: The Women's Environmental Cancer and Radiation Epidemiology Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRCLINONC.2013.41

Relationship between potentially modifiable lifestyle factors and risk of second primary contralateral breast cancer among women diagnosed with estrogen receptor-positive invasive breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRCLINONC.2013.41

Incidence of invasive cancers following squamous cell skin cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRCLINONC.2013.41

The incidence of malignant melanoma in the United States: issues as we approach the 21st century

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRCLINONC.2013.41

Cancer screening in the United States, 2011: A review of current American Cancer Society guidelines and issues in cancer screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRCLINONC.2013.41

American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRCLINONC.2013.41

Prospective study of breast cancer incidence in women with a BRCA1 or BRCA2 mutation under surveillance with and without magnetic resonance imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRCLINONC.2013.41

Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRCLINONC.2013.41

Letrozole therapy alone or in sequence with tamoxifen in women with breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRCLINONC.2013.41

Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 100-month analysis of the ATAC trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRCLINONC.2013.41

Long-term results of tamoxifen prophylaxis for breast cancer--96-month follow-up of the randomized IBIS-I trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRCLINONC.2013.41

Exemestane for breast-cancer prevention in postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRCLINONC.2013.41

Tamoxifen for the prevention of breast cancer: current status of the National Surgical Adjuvant Breast and Bowel Project P-1 study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRCLINONC.2013.41

Effects of tamoxifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes: the NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRCLINONC.2013.41

Preventive therapy for breast cancer: a consensus statement

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRCLINONC.2013.41

Influence of a diet very high in vegetables, fruit, and fiber and low in fat on prognosis following treatment for breast cancer: the Women's Healthy Eating and Living (WHEL) randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRCLINONC.2013.41

Dietary fat reduction and breast cancer outcome: interim efficacy results from the Women's Intervention Nutrition Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRCLINONC.2013.41

State of the epidemiological evidence on physical activity and cancer prevention.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRCLINONC.2013.41

Screening for ovarian cancer: U.S. Preventive Services Task Force reaffirmation recommendation statement

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRCLINONC.2013.41

Recommendations for follow-up care of individuals with an inherited predisposition to cancer. I. Hereditary nonpolyposis colon cancer. Cancer Genetics Studies Consortium

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRCLINONC.2013.41

Recommendations for follow-up care of individuals with an inherited predisposition to cancer. II. BRCA1 and BRCA2. Cancer Genetics Studies Consortium

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRCLINONC.2013.41

Recommendations for the care of individuals with an inherited predisposition to Lynch syndrome: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRCLINONC.2013.41

Familial ovarian cancer screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRCLINONC.2013.41

Ovarian cancer and oral contraceptives: collaborative reanalysis of data from 45 epidemiological studies including 23,257 women with ovarian cancer and 87,303 controls

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRCLINONC.2013.41

The use of hormonal contraception and its protective role against endometrial and ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRCLINONC.2013.41

Cancer risk among users of oral contraceptives: cohort data from the Royal College of General Practitioner's oral contraception study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRCLINONC.2013.41

Referral for cancer genetics consultation: a review and compilation of risk assessment criteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRCLINONC.2013.41

Long-term effect of aspirin on colorectal cancer incidence and mortality: 20-year follow-up of five randomised trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRCLINONC.2013.41

Aspirin in the Chemoprevention of Colorectal Neoplasia: An Overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRCLINONC.2013.41

Reduced lung-cancer mortality with low-dose computed tomographic screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRCLINONC.2013.41

Cancer risks for male carriers of germline mutations in BRCA1 or BRCA2: a review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRCLINONC.2013.41

American Cancer Society guideline for the early detection of prostate cancer: update 2010

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRCLINONC.2013.41

Management of familial melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRCLINONC.2013.41

Screening for cutaneous melanoma by skin self-examination

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRCLINONC.2013.41

Leveraging epidemiology and clinical studies of cancer outcomes: recommendations and opportunities for translational research

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRCLINONC.2013.41

Cancer pharmacogenomics: strategies and challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRCLINONC.2013.41

Cancer pharmacogenomics and pharmacoepidemiology: setting a research agenda to accelerate translation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRCLINONC.2013.41

Testicular cancer survivorship: research strategies and recommendations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRCLINONC.2013.41

Genetically mediated Nf1 loss in mice promotes diverse radiation-induced tumors modeling second malignant neoplasms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRCLINONC.2013.41

Cancer risk prediction models: a workshop on development, evaluation, and application

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRCLINONC.2013.41

Yield of screening for long-term complications using the children's oncology group long-term follow-up guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRCLINONC.2013.41

Occurrence of multiple subsequent neoplasms in long-term survivors of childhood cancer: a report from the childhood cancer survivor study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRCLINONC.2013.41

Long-Term Survival Among Patients With Hodgkin's Lymphoma Who Developed Breast Cancer: A Population-Based Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRCLINONC.2013.41

Therapy-associated solid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRCLINONC.2013.41

Second malignant neoplasms and cardiovascular disease following radiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRCLINONC.2013.41

The calculated risk of fatal secondary malignancies from intensity-modulated radiation therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRCLINONC.2013.41

Cancer risk in women with previous breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRCLINONC.2013.41

Second Malignant Neoplasms Among Long-Term Survivors of Hodgkin’s Disease: A Population-Based Evaluation Over 25 Years

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRCLINONC.2013.41

Long-Term Solid Cancer Risk Among 5-Year Survivors of Hodgkin's Lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRCLINONC.2013.41

Second Cancers Among 40 576 Testicular Cancer Patients: Focus on Long-term Survivors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRCLINONC.2013.41

Second Cancers Among 104760 Survivors of Cervical Cancer: Evaluation of Long-Term Risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRCLINONC.2013.41

The rate of secondary malignancies after radical prostatectomy versus external beam radiation therapy for localized prostate cancer: a population-based study on 17,845 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRCLINONC.2013.41

Breast Cancer Following Radiotherapy and Chemotherapy Among Young Women With Hodgkin Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRCLINONC.2013.41

Lenalidomide Maintenance after Stem-Cell Transplantation for Multiple Myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRCLINONC.2013.41

Treatment-Associated Leukemia Following Testicular Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRCLINONC.2013.41

Five Years of Letrozole Compared With Tamoxifen As Initial Adjuvant Therapy for Postmenopausal Women With Endocrine-Responsive Early Breast Cancer: Update of Study BIG 1-98

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRCLINONC.2013.41

Cancer survivors: living longer, and now, better

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRCLINONC.2013.41

Second malignancy risk associated with treatment of Hodgkin's lymphoma: meta-analysis of the randomised trials

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRCLINONC.2013.41

Patterns of subsequent malignancies after Hodgkin lymphoma in children and adults

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRCLINONC.2013.41

Angiosarcoma arising in the breast following breast-conserving surgery with radiation for breast carcinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRCLINONC.2013.41

Lung cancer after radiation therapy for breast cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRCLINONC.2013.41

Increased risk of squamous cell esophageal cancer after adjuvant radiation therapy for primary breast cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRCLINONC.2013.41

Cancer in the contralateral breast after radiotherapy for breast cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRCLINONC.2013.41

Involved-node radiotherapy (INRT) in patients with early Hodgkin lymphoma: Concepts and guidelines

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRCLINONC.2013.41

Put the “hockey stick” on ice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRCLINONC.2013.41

Para-aortic irradiation for stage I testicular seminoma: results of a prospective study in 675 patients. A trial of the German testicular cancer study group (GTCSG).

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRCLINONC.2013.41

Second malignancy after Hodgkin disease treated with radiation therapy with or without chemotherapy: long-term risks and risk factors

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRCLINONC.2013.41

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRCLINONC.2013.41

Risk of leukemia after platinum-based chemotherapy for ovarian cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRCLINONC.2013.41

Risk of Second Malignancy After Non-Hodgkin's Lymphoma: A British Cohort Study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRCLINONC.2013.41

Secondary colorectal carcinoma after childhood cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRCLINONC.2013.41

Secondary cancers after bone marrow transplantation for leukemia or aplastic anemia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRCLINONC.2013.41

Secondary leukaemia and myelodysplasia after autografting for lymphoma: results from the EBMT. EBMT Lymphoma and Late Effects Working Parties. European Group for Blood and Marrow Transplantation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRCLINONC.2013.41

Risk of metachronous breast cancer after BRCA mutation-associated ovarian cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRCLINONC.2013.41

Genetic susceptibility to radiogenic cancer in humans

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRCLINONC.2013.41

Polygenic susceptibility to breast cancer and implications for prevention

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRCLINONC.2013.41

A polymorphism in the XPD gene predisposes to leukemic transformation and new nonmyeloid malignancies in essential thrombocythemia and polycythemia vera

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRCLINONC.2013.41

Breast cancer risk factors and second primary malignancies among women with breast cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRCLINONC.2013.41

Multiple primary melanoma: two-year results from a population-based study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRCLINONC.2013.41

Increased risk of contralateral breast cancers among overweight and obese women: a time-dependent association

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRCLINONC.2013.41

Risk factors for second primary tumours in breast cancer survivors

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRCLINONC.2013.41

Nutrition and physical activity guidelines for cancer survivors

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRCLINONC.2013.41

Antioxidant vitamins supplementation and mortality: a randomized trial in head and neck cancer patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRCLINONC.2013.41

Population-based surveillance by colonoscopy: effect on the incidence of colorectal cancer. Telemark Polyp Study I

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRCLINONC.2013.41

Report from the Rockefellar Foundation Sponsored International Workshop on reducing mortality and improving quality of life in long-term survivors of Hodgkin's disease: July 9-16, 2003, Bellagio, Italy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRCLINONC.2013.41

A patient with 17 primary tumours and a germ line mutation in TP53: tumour induction by adjuvant therapy?

31 March 2020

1 reference

12 December 2020

Malignant neoplasms following bone marrow transplantation.

1 reference

12 December 2020

Randomized trial of supplemental beta-carotene to prevent second head and neck cancer.

1 reference

12 December 2020

Risk of lymphoproliferative disorders after bone marrow transplantation: a multi-institutional study

1 reference

12 December 2020

Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5 years' adjuvant treatment for breast cancer.

1 reference

12 December 2020

Myelodysplastic syndromes arising in patients with germline TP53 mutation and Li-Fraumeni syndrome

1 reference

12 December 2020

Predictors of therapy-related leukemia and myelodysplasia following autologous transplantation for lymphoma: an assessment of risk factors

1 reference

12 December 2020

Different genetic pathways in leukemogenesis for patients presenting with therapy-related myelodysplasia and therapy-related acute myeloid leukemia

1 reference

12 December 2020

10.1038/NRCLINONC.2013.41

Identifiers

DOI

1 reference

Dimensions Publication ID

28 August 2017

1015819286

0 references

1 reference